1887

Abstract

Gamma interferon (IFN-) expression plays a crucial role in the control of mammalian hepatitis B virus (HBV) infection. However, the role of duck INF- (DuIFN-) in the outcome of duck HBV (DHBV) infection, a reference model for hepadnavirus replication studies, has not yet been investigated. This work explored the dynamics of DuIFN- expression in liver and peripheral blood mononuclear cells (PBMCs) during resolution of DHBV infection in adolescent ducks in relation to serum and liver markers of virus replication, histological changes and humoral response induction. DHBV infection of 3-week-old ducks resulted in transient expression of intrahepatic preS protein (days 3–14) and mild histological changes. Low-level viraemia was detected only during the first 10 days of infection and was accompanied by early anti-preS antibody response induction. Importantly, a strong increase in intrahepatic DuIFN- RNA was detected by real-time RT-PCR at days 6–14, which coincided with a sharp decrease in both viral DNA and preS protein in the liver. Interestingly, liver DuIFN- expression remained augmented to the end of the follow-up period (day 66) and correlated with portal lymphocyte infiltration and persistence of trace quantities of intrahepatic DHBV DNA in animals that had apparently completely resolved the infection. Moreover, in infected ducks, a moderate increase was detected in the levels of DuIFN- in PBMCs (days 12–14), which coincided with the peak in liver DuIFN- RNA levels. These data reveal that increased DuIFN- expression in liver and PBMCs is concomitant with viral clearance, characterizing the resolution of infection, and provide new insights into the host–virus interactions that control DHBV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82170-0
2006-11-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/11/3225.html?itemId=/content/journal/jgv/10.1099/vir.0.82170-0&mimeType=html&fmt=ahah

References

  1. Abel K., Alegria-Hartman M. J., Zanotto K., McChesney M. B., Marthas M. L., Miller C. J. 2001; Anatomic site and immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal rhesus macaques. Cytokine 16:191–204 [CrossRef]
    [Google Scholar]
  2. Abel K., La Franco-Scheuch L., Rourke T., Ma Z.-M., de Silva V., Fallert B., Beckett L., Reinhart T. A., Miller C. J. 2004; Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol 78:841–854 [CrossRef]
    [Google Scholar]
  3. Barraud L., Guerret S., Chevallier M., Borel C., Jamard C., Trepo C., Wild C. P., Cova L. 1999; Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Hepatology 29:1317–1323 [CrossRef]
    [Google Scholar]
  4. Cavanaugh V. J., Guidotti L. G., Chisari F. V. 1998; Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 72:2630–2637
    [Google Scholar]
  5. Chassot S., Lambert V., Kay A., Godinot C., Trepo C., Cova L. 1994; Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning. Virology 200:72–78 [CrossRef]
    [Google Scholar]
  6. Cova L., Zoulim F. 2004; Duck hepatitis B virus model in the study of hepatitis B virus. Methods Mol Med 96:261–268
    [Google Scholar]
  7. Guidotti L. G., Chisari F. V. 2001; Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65–91 [CrossRef]
    [Google Scholar]
  8. Guidotti L. G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F. V. 1999; Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825–829 [CrossRef]
    [Google Scholar]
  9. Hodgson P. D., Michalak T. 2001; Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34:1049–1059 [CrossRef]
    [Google Scholar]
  10. Jilbert A. R., Wu T.-T., England J. M., Hall P. da la M., Carp N. Z., O'Connell A. P., Mason W. S. 1992; Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66:1377–1388
    [Google Scholar]
  11. Jilbert A. R., Botten J. A., Miller D. S., Bertram E. M., Hall P. de la M., Kotlarski J., Burrell C. J. 1998; Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology 244:273–282 [CrossRef]
    [Google Scholar]
  12. Klöcker U., Schultz U., Schaller H., Protzer U. 2000; Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 74:5525–5533 [CrossRef]
    [Google Scholar]
  13. Le Guerhier F., Thermet A., Guerret S., Chevallier M., Jamard C., Gibbs C. S., Trépo C., Cova L., Zoulim F. 2003; Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model. J Hepatol 38:328–334
    [Google Scholar]
  14. Le Mire M. F., Miller D. S., Foster W. K., Burrell C. J., Jilbert A. R. 2005; Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. J Virol 79:12242–12252 [CrossRef]
    [Google Scholar]
  15. Menne S., Wang Y., Butler S. D., Gerin J. L., Cote P. J., Tennant B. C. 2002; Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck ( Marmota monax ). Vet Immunol Immunopathol 87:97–105 [CrossRef]
    [Google Scholar]
  16. Rehermann B., Nascimbeni M. 2005; Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5:215–229 [CrossRef]
    [Google Scholar]
  17. Rehermann B., Ferrari C., Pasquinelli C., Chisari F. V. 1996; The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2:1104–1108 [CrossRef]
    [Google Scholar]
  18. Rollier C., Sunyach C., Barraud L., Madani N., Jamard C., Trepo C., Cova L. 1999; Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 116:658–665 [CrossRef]
    [Google Scholar]
  19. Rollier C., Charollois C., Jamard C., Trepo C., Cova L. 2000; Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein. Vaccine 18:3091–3096 [CrossRef]
    [Google Scholar]
  20. Schultz U., Chisari F. V. 1999; Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol 73:3162–3168
    [Google Scholar]
  21. Seignères B., Martin P., Werle B., Schorr O., Jamard C., Rimsky L., Trepo C., Zoulim F. 2003; Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. Antimicrob Agents Chemother 47:1842–1852 [CrossRef]
    [Google Scholar]
  22. Sunyach C., Rollier C., Robaczewska M., Borel C., Barraud L., Kay A., Trepo C., Will H., Cova L. 1999; Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction. J Virol 73:2569–2575
    [Google Scholar]
  23. Thermet A., Rollier C., Zoulim F., Trepo C., Cova L. 2003; Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine 21:659–662 [CrossRef]
    [Google Scholar]
  24. Urban S., Schwarz C., Marx U. C., Zentgraf H., Schaller H., Multhaup G. 2000; Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus–receptor interaction. EMBO J 19:1217–1227 [CrossRef]
    [Google Scholar]
  25. Vickery K., Cossart Y., Gu X., Dixon R. 1997; Antigen-specific blastogenesis assays for duck hepatitis B virus using duck peripheral blood and splenic mononuclear cells. Vet Immunol Immunopathol 59:349–358 [CrossRef]
    [Google Scholar]
  26. Wieland S. F., Chisari F. V. 2005; Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79:9369–9380 [CrossRef]
    [Google Scholar]
  27. Wieland S. F., Spangenberg H. C., Thimme R., Purcell R. H., Chisari F. V. 2004; Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A 101:2129–2134 [CrossRef]
    [Google Scholar]
  28. Zhang Y.-Y., Summers J. 2004; Rapid production of neutralizing antibody levels leads to transient hepadnavirus infection. J Virol 78:1195–1201 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82170-0
Loading
/content/journal/jgv/10.1099/vir.0.82170-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error